AZT

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Azt Adverse Events Reported to the FDA Over Time

How are Azt adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Azt, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Azt is flagged as the suspect drug causing the adverse event.

Most Common Azt Adverse Events Reported to the FDA

What are the most common Azt adverse events reported to the FDA?

Drug Exposure During Pregnancy	49 (8.18%)
Joint Dislocation	16 (2.67%)
Anaemia	10 (1.67%)
Aspartate Aminotransferase Increase...	9 (1.5%)
Premature Baby	9 (1.5%)
Alanine Aminotransferase Increased	8 (1.34%)
Hydrocele	8 (1.34%)
Polydactyly	8 (1.34%)
Pregnancy	8 (1.34%)
Ventricular Septal Defect	7 (1.17%)
Blood Creatine Phosphokinase Increa...	6 (1%)
	Show More
Haemoglobin Decreased	6 (1%)
Hepatomegaly	6 (1%)
Hyporeflexia	6 (1%)
Weight Decreased	6 (1%)
Abortion Spontaneous	5 (.83%)
Caesarean Section	5 (.83%)
Eating Disorder	5 (.83%)
Hypoglycaemia	5 (.83%)
Macrocytosis	5 (.83%)
Muscle Atrophy	5 (.83%)
Neonatal Disorder	5 (.83%)
Neutrophil Count Decreased	5 (.83%)
Poor Sucking Reflex	5 (.83%)
Small For Dates Baby	5 (.83%)
Anaemia Macrocytic	4 (.67%)
Atrioventricular Septal Defect	4 (.67%)
Blood Amylase Increased	4 (.67%)
Blood Glucose Decreased	4 (.67%)
Blood Potassium Increased	4 (.67%)
Blood Uric Acid Increased	4 (.67%)
Hepatosplenomegaly	4 (.67%)
Hydrocephalus	4 (.67%)
Hypospadias	4 (.67%)
Immune Reconstitution Syndrome	4 (.67%)
Metabolic Acidosis	4 (.67%)
Pneumonia	4 (.67%)
Pyrexia	4 (.67%)
Umbilical Hernia	4 (.67%)
Abdominal Distension	3 (.5%)
Bradycardia	3 (.5%)
Breech Presentation	3 (.5%)
Congenital Anomaly	3 (.5%)
Congenital Naevus	3 (.5%)
Cryptorchism	3 (.5%)
Developmental Delay	3 (.5%)
Drug Ineffective	3 (.5%)
Drug Level Increased	3 (.5%)
Enterocolitis	3 (.5%)
Erythema	3 (.5%)
Feeling Jittery	3 (.5%)
Gastrointestinal Disorder	3 (.5%)
Hyperbilirubinaemia	3 (.5%)
Intestinal Dilatation	3 (.5%)
Jaundice	3 (.5%)
Lipodystrophy Acquired	3 (.5%)
Lipohypertrophy	3 (.5%)
Microcephaly	3 (.5%)
Micrognathia	3 (.5%)
Neuromyopathy	3 (.5%)
Neutropenia	3 (.5%)
Overdose	3 (.5%)
Sepsis	3 (.5%)
Trisomy 21	3 (.5%)
Abortion Induced	2 (.33%)
Acoustic Stimulation Tests Abnormal	2 (.33%)
Anaemia Megaloblastic	2 (.33%)
Anastomotic Leak	2 (.33%)
Apnoea	2 (.33%)
Blood Phosphorus Increased	2 (.33%)
Bronchopneumonia	2 (.33%)
Cerebral Ventricle Dilatation	2 (.33%)
Choanal Atresia	2 (.33%)
Condition Aggravated	2 (.33%)
Congenital Hepatomegaly	2 (.33%)
Convulsion	2 (.33%)
Cough	2 (.33%)
Cyanosis	2 (.33%)
Cyst	2 (.33%)
Diarrhoea	2 (.33%)
Disease Progression	2 (.33%)
Disseminated Intravascular Coagulat...	2 (.33%)
Drug Intolerance	2 (.33%)
Drug Toxicity	2 (.33%)
Echocardiogram Abnormal	2 (.33%)
Eye Discharge	2 (.33%)
Fatigue	2 (.33%)
Fungal Infection	2 (.33%)
Gene Mutation	2 (.33%)
General Physical Health Deteriorati...	2 (.33%)
Hepatitis A	2 (.33%)
Hiv Antibody Positive	2 (.33%)
Human Immunodeficiency Virus Transm...	2 (.33%)
Hypoglycaemia Neonatal	2 (.33%)
Hypotension	2 (.33%)
Intestinal Malrotation	2 (.33%)
Lymphoma	2 (.33%)
Mediastinitis	2 (.33%)
Myocardial Infarction	2 (.33%)
Myopathy	2 (.33%)
Nasal Congestion	2 (.33%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Azt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Azt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Azt

What are the most common Azt adverse events reported to the FDA?

Chemical Injury And Poisoning	52 (8.68%)
Hepatobiliary	22 (3.67%)
Hepatic And Hepatobiliary	21 (3.51%)
Anemias Nonhemolytic And Marrow Dep...	19 (3.17%)
Neonatal And Perinatal Conditions	19 (3.17%)
Neurological	18 (3.01%)
Hematology Investigations	17 (2.84%)
Bone And Joint Injuries	16 (2.67%)
Musculoskeletal And Connective Tiss...	16 (2.67%)
Reproductive Tract And Breast Disor...	16 (2.67%)
Infections - Pathogen Unspecified	15 (2.5%)
	Show More
Cardiac And Vascular Disorders Cong...	13 (2.17%)
Pregnancy, Labour, Delivery And Pos...	12 (2%)
Metabolic, Nutritional And Blood Ga...	10 (1.67%)
Respiratory	10 (1.67%)
Therapeutic And Nontherapeutic Effe...	10 (1.67%)
Abortions And Stillbirth	8 (1.34%)
Epidermal And Dermal Conditions	8 (1.34%)
Gastrointestinal Signs	8 (1.34%)
Muscle	8 (1.34%)
Chromosomal Abnormalities And Abnor...	7 (1.17%)
Gastrointestinal Tract Disorders Co...	7 (1.17%)
Glucose Metabolism Disorders	7 (1.17%)
Obstetric And Gynecological Therape...	7 (1.17%)
Respiratory Disorders Congenital	7 (1.17%)
Skin And Subcutaneous Tissue	7 (1.17%)
Water, Electrolyte And Mineral	7 (1.17%)
Acid-base	6 (1%)
Enzyme	6 (1%)
Physical Examination Topics	6 (1%)
Viral Infectious	6 (1%)
Body Temperature Conditions	5 (.83%)
Eating Disorders	5 (.83%)
Gastrointestinal Motility And Defec...	5 (.83%)
Musculoskeletal And Connective Tiss...	5 (.83%)
Red Blood Cell	5 (.83%)
White Blood Cell	5 (.83%)
Abdominal Hernias And Other Abdomin...	4 (.67%)
Bacterial Infectious	4 (.67%)
Cardiac Arrhythmias	4 (.67%)
Fungal Infectious	4 (.67%)
Gastrointestinal	4 (.67%)
Gastrointestinal Conditions	4 (.67%)
Gastrointestinal Inflammatory Condi...	4 (.67%)
Gastrointestinal Stenosis And Obstr...	4 (.67%)
Immunodeficiency Syndromes	4 (.67%)
Increased Intracranial Pressure And...	4 (.67%)
Neurological Disorders Congenital	4 (.67%)
Neuromuscular	4 (.67%)
Skin And Subcutaneous Tissue Disord...	4 (.67%)
Upper Respiratory Tract Disorders	4 (.67%)
Appetite And General Nutritional	3 (.5%)
Cardiac And Vascular Investigations	3 (.5%)
Cardiac Disorder Signs	3 (.5%)
Congenital And Hereditary	3 (.5%)
Coronary Artery	3 (.5%)
Fetal Complications	3 (.5%)
Medication Errors	3 (.5%)
Toxicology And Therapeutic Drug Mon...	3 (.5%)
Ancillary Infectious Topics	2 (.33%)
Coagulopathies And Bleeding Diathes...	2 (.33%)
Decreased And Nonspecific Blood Pre...	2 (.33%)
Electrolyte And Fluid Balance Condi...	2 (.33%)
Gastrointestinal Hemorrhages	2 (.33%)
Headaches	2 (.33%)
Hepatobiliary Disorders Congenital	2 (.33%)
Lower Respiratory Tract Disorders	2 (.33%)
Lymphomas	2 (.33%)
Microbiology And Serology	2 (.33%)
Mycobacterial Infectious	2 (.33%)
Neurological, Special Senses And Ps...	2 (.33%)
Ocular Infections, Irritations And ...	2 (.33%)
Pleural	2 (.33%)
Procedural And Device Related Injur...	2 (.33%)
Renal And Urinary Tract Investigati...	2 (.33%)
Seizures	2 (.33%)
Structural Brain	2 (.33%)
Tissue	2 (.33%)
Administration Site Reactions	1 (.17%)
Allergic Conditions	1 (.17%)
Angiedema And Urticaria	1 (.17%)
Bone Disorders	1 (.17%)
Bronchial Disorders	1 (.17%)
Cardiac Valve	1 (.17%)
Deliria	1 (.17%)
Disturbances In Thinking	1 (.17%)
Encephalopathies	1 (.17%)
Exocrine Pancreas Conditions	1 (.17%)
Eye Disorders Congenital	1 (.17%)
Fatal Outcomes	1 (.17%)
Hearing	1 (.17%)
Heart Failures	1 (.17%)
Hematopoietic Neoplasms	1 (.17%)
Hemolyses And Related Conditions	1 (.17%)
Injuries	1 (.17%)
Investigations, Imaging And Histopa...	1 (.17%)
Lipid Analyses	1 (.17%)
Lymphomas Non-hodgkins B-cell	1 (.17%)
Lymphomas Non-hodgkins T-cell	1 (.17%)
Musculoskeletal And Connective Tiss...	1 (.17%)
Neoplasm Related Morbidities	1 (.17%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Azt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Azt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Azt According to Those Reporting Adverse Events

Why are people taking Azt, according to those reporting adverse events to the FDA?

Hiv Infection	150
Antiretroviral Therapy	77
Prophylaxis Against Hiv Infection	38
Drug Use For Unknown Indication	31
Drug Exposure During Pregnancy	23
Product Used For Unknown Indication	16
	Show More
Antiviral Prophylaxis	7
Malaria Prophylaxis	7
Acquired Immunodeficiency Syndrome	6
Maternal Exposure During Pregnancy	5
Hiv Test Positive	5
Antiviral Treatment	4
Immunodeficiency	2
Crohns Disease	2
Human Immunodeficiency Virus Transm...	2
Prophylaxis	1
Hepatitis	1
Lentivirus Test Positive	1
Hiv Test	1
Proctocolitis	1
Foetal Exposure During Pregnancy	1
Viral Infection	1

Azt Case Reports

What Azt safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Azt. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Azt.